Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06221176 · ClinicalTrials.gov registry record · NA

Biomarkers Research in Anxiety for Validation and Efficacy

A NA study of Autism Spectrum Disorder and Autism, sponsored by Boston Children's Hospital.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT06221176 is a NA study of Autism Spectrum Disorder and Autism that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 25 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06221176, a NA study of Autism Spectrum Disorder and Autism, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

A within-subjects design will be used for this preliminary investigation of four biomarkers across two contexts of use: prediction of treatment response (i.e., stratification) and quantification of response (i.e., change).

Interventions

  • BEHAVIORAL Being Brave

Study Locations (1)

Massachusetts

  • Boston Children's Hospital, Two Brookline Place - Brookline

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-04-02
Est. Completion 2025-08-01
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT06221176

The ClinicalTrials.gov registry entry for NCT06221176 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (81% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Being Brave is the first listed.

NCT06221176 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06221176 about?

NCT06221176 is a clinical study titled "Biomarkers Research in Anxiety for Validation and Efficacy". A within-subjects design will be used for this preliminary investigation of four biomarkers across two contexts of use: prediction of treatment response (i.e., stratification) and quantification of response (i.e., change).

What is the current status of trial NCT06221176?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-04-02. Estimated completion is 2025-08-01.

What conditions does trial NCT06221176 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism.

What interventions are being tested in trial NCT06221176?

The interventions under investigation include: Being Brave (BEHAVIORAL).

Who is sponsoring clinical trial NCT06221176?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06221176 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.